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Aims
The Fluid Lavage in Open Fracture Wounds (FLOW) trial was a multicentre, blinded, 
randomized controlled trial that used a 2 × 3 factorial design to evaluate the effect of 
irrigation solution (soap versus normal saline) and irrigation pressure (very low versus low 
versus high) on health-related quality of life (HRQL) in patients with open fractures. In this 
study, we used this dataset to ascertain whether these factors affect whether HRQL returns 
to pre-injury levels at 12-months post-injury.
Patients and Methods
Participants completed the Short Form-12 (SF-12) and the EuroQol-5 Dimensions (EQ-5D) at 
baseline (pre-injury recall), at two and six weeks, and at three, six, nine and 12-months post-
fracture. We calculated the Physical Component Score (PCS) and the Mental Component 
Score (MCS) of the SF-12 and the EQ-5D utility score, conducted an analysis using a multi-
level generalized linear model, and compared differences between the baseline and 12-
month scores.
Results
We found no clinically important differences between irrigating solutions or pressures for 
the SF-12 PCS, SF-12 MCS and EQ-5D. Irrespective of treatment, participants had not 
returned to their pre-injury function at 12-months for any of the three outcomes (p < 0.001).
Conclusion
Neither the composition of the irrigation solution nor irrigation pressure applied had an 
effect on HRQL. Irrespective of treatment, patients had not returned to their pre-injury HRQL 
at 12 months post-fracture.
Cite this article: Bone Joint J 2018;100-B:88–94.
Open fractures are debilitating injuries fre-
quently complicated by infection and problems
associated with wound and fracture healing.1-3
Their initial management includes thorough
irrigation and debridement to remove debris
and necrotic tissue.4 There has been uncertainty
over the choice of irrigating pressure and solu-
tion on both the rate of complications and
patients’ health-related quality of life (HRQL)
after open fractures.4-6 Used in conjunction with
clinical outcomes, HRQL is highly relevant for
the evaluation of fracture treatment and there
has been an increase in its use in fracture trials.7
The Fluid Lavage in Open Fracture Wounds
(FLOW) trial was a prospective, multicentre,
randomized controlled trial that evaluated the
effect of irrigation solution and pressure on
rates of re-operation in 2447 adult patients.3,8
Patients were randomized to one of three irri-
gating pressures: very-low pressure (1 psi to
2 psi), low pressure (5 psi to 10 psi), or high
pressure (> 20 psi), and one of two irrigating
solutions: 0.45% solution of castile soap (Cas-
tile Soap, Triad Medical, Hartland and Apli-
care Inc., Meriden, Connecticut) or sterile
normal saline alone. The primary outcome was
a composite of re-operation, defined as surgery
within 12 months of the initial procedure to
treat infection at the operative site, manage-
ment of wound-healing problems and promo-
tion of bone healing. The assessment of HRQL
for 12 months post-fracture was an a priori
planned part of statistical analysis.8 In the cur-
rent study, we aimed to determine: the impact
of the composition of the irrigation solution
and pressure of its delivery on HRQL and if
patient HRQL returns to pre-fracture levels by
12-months post-fracture.
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Patients and Methods
FLOW trial. Details of trial methodology and primary out-
come results have previously been published.3,8 Research
Ethics Board approval for the trial was obtained at the co-
ordinating centre (McMaster University) (REB: 08-268)
and at each clinical site. The trial was prospectively regis-
tered at clinicaltrials.gov (NCT00788398).
HRQL. As a secondary outcome, patients enrolled in the
FLOW study were asked to complete the 12-Item Short
Form Health Survey (SF-12)9 and the EuroQol-5 Dimen-
sions Questionnaire (EQ-5D)10 on recruitment to the trial
(being asked to rate their pre-injury state), at two and six
weeks, and at three, six, nine and 12-months post-
injury.11
The SF-12 physical (PCS) and mental component scores
(MCS) and EQ-5D index score were calculated according
to the developers’ recommendations. In our main analy-
ses, we included patients where the SF-12 PCS, the SF-12
MCS or the EQ-5D score could be calculated for at least
one follow-up visit between two weeks and 12 months.
Sample size. Sample size for the HRQL analysis was a fac-
tor in the development of the FLOW protocol.8 We consid-
Table I. Patient characteristics and surgical and peri-operative management
HRQL cohort, n = 1860 Total FLOW cohort, n = 2447
Mean age (yrs) (SD) 45.4 (17.6), n = 1860 45.2 (17.8)*
Gender, n (%)
Male 1273/1860 (68.4) 1680/2428 (69.2)
Female 587/1860 (31.6) 748/2428 (30.8)
Current smokers, n (%) 614/1857 (33.1) 777/2405 (32.3)
Work-related injuries, n (%) 295/1859 (15.9) 349/2419 (14.4)
Mechanism of injury, n (%)
Motor vehicle accident (driver/passenger) 431/1860 (23.2) 613/2428 (25.2)
Motor vehicle accident (pedestrian) 197/1860 (10.6) 304/2428 (12.5)
Motorcycle accident 330/1860 (17.7) 414/2428 (17.1)
All-terrain vehicle accident 42/1860 (2.3) 47/2428 (1.9)
Crush injury 93/1860 (5.0) 116/2428 (4.8)
Fall from standing 202/1860 (10.9) 261/2428 (10.7)
Fall from height 352/1860 (18.9) 422/2428 (17.4)
Twist 25/1860 (1.3) 26/2428 (1.1)
Direct trauma (penetrating) 64/1860 (3.4) 74/2428 (3.0)
Direct trauma (blunt) 117/1860 (6.3) 141/2428 (5.8)
Explosion 1/1860 (0.1) 2/2428 (0.1)
Bicycle accident 5/1860 (0.3) 6/2428 (0.2)
Plane crash 1/1860 (0.1) 1/2428 (0.04)
Other 0/1860 (0.0) 1/2428 (0.04)
Major concomitant trauma, n (%)
Head injury 103/1860 (5.5) 145/2429 (6.0)
Chest injury 124/1860 (6.7) 187/2429 (7.7)
Intra-abdominal injury 67/1860 (3.6) 95/2429 (3.9)
Any of the above 233/1860 (12.5) 328/2429 (13.5)
Gustilo Type, n (%)
Type I 463/1857 (24.9) 639/2419 (26.4)
Type II 703/1857 (37.9) 899/2419 (37.2)
Type IIIA 526/1857 (28.3) 649/2419 (26.8)
Type IIIB 165/1857 (8.9) 232/2419 (9.6)
Location of fracture, n (%)
Arm 554/1860 (29.8) 758/2428 (31.2)
Leg 1306/1860 (70.2) 1670/2428 (68.8)
Hours to first incision from injury, median (IQR) 10.0 (6.4 to 15.9), n = 1832 9.8 (6.4 to 15.9), n = 2374
Surgical preparation solution, n (%)
Iodine or providone-iodine 1000/1852 (54.0) 1394/2413 (57.8)
Chlorhexidine 930/1852 (50.2) 1100/2413 (45.6)
Alcohol 294/1852 (15.9) 436/2413 (18.1)
Other 11/1852 (0.6) 14/2413 (0.6)
Definitive fixation, n (%)
Intramedullary nail 635/1860 (34.1) 821/2422 (33.9)
External fixator 33/1860 (1.8) 59/2422 (2.4)
Plate 962/1860 (51.7) 1218/2422 (50.3)
Other internal fixation 221/1860 (11.9) 308/2422 (12.7)
Other 9/1860 (0.5) 16/2422 (0.7)
*the ages of four patients in the FLOW cohort were not known. Mean age was calculated with n = 2443
HRQL, health-related quality of life; FLOW, Fluid Lavage in Open Fracture Wounds; IQR, interquartile range
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ered an important difference in SF-12 to correspond to a
moderate effect as described by Cohen12 and noted the min-
imally important difference in the SF-12 reported by Ware
et al.9 In both cases, the value is 0.5 SD, equivalent to a five-
point difference in the score. Specifying an α-level of 0.01
and a β-level of 0.20 (study power = 0.80), we required a
sample of at least 405 patients (135 in each of three
groups).
Initial sample size calculations for the EQ-5D were based
on previous literature suggesting that a 0.03 to 0.04 incre-
mental change in the Health Utilities Index (HUI)13 repre-
sents a patient-important difference,14 and that the EQ-5D
correlates well with the HUI.15 We needed to recruit at least
329 patients in each of the three groups (α-level = 0.01,
β = 0.20, difference = 0.04, σ = 0.15).
Data analysis. Our main analyses were based on multi-level
generalized linear models, each comprising three levels (the
clinical site, patient and time of HRQL assessment (i.e.
visit)). We included the following independent variables:
nature of the irrigation solution, pressure of irrigation, time
point, baseline HRQL score and type of fracture (Gustilo
type I/II vs. type III).16
Given that the FLOW trial evaluated both the pressure of
and solution used for irrigation in the same patient popula-
tion, we first ran the above model with an additional solu-
tion by a pressure interaction term, to identify any
interaction between the two treatment factors. We planned
a priori to remove from the model any interaction terms
that were not significant.
Our final model for SF-12 PCS included the following
independent variables: randomized solution, randomized
pressure, time of HRQL assessment, pre-injury SF-12 PCS,
fracture type and interaction of time of HRQL assessment
by fracture type. 
None of the interactions were significant in the analysis
of the SF-12 MCS. The model therefore included: solution,
pressure, time point, pre-injury SF-12 MCS and fracture
type. The interaction of time point by fracture type was the
only significant interaction term in the model for the EQ-
5D. This model therefore included solution, pressure, time
point, pre-injury EQ-5D score, fracture type and the inter-
action of time point by fracture type.
In addition to our main analysis, we performed an
adjusted analysis that added factors to these models. These
factors were: age, arm versus leg injury, postoperative frac-
ture gap, initial method of internal fixation and severity of
wound contamination.
We also conducted two a priori subgroup analyses for
the SF-12 PCS, SF-12 MCS and EQ-5D scores, which were
fracture type (Gustilo Type I or II versus Gustilo Type III);16
and fracture location (arm versus leg).
The mean scores and SDs for the SF-12 PCS, SF-12 MCS
and EQ-5D were plotted over time by solution treatment
group and pressure treatment group. Mean differences
between the baseline (pre-injury) SF-12 PCS, SF-12 MCS
and EQ-5D scores and the corresponding 12-month
scores were calculated and compared using paired t-tests.




























Soap (PCS) Saline (PCS) Soap (MCS) Saline (MCS)
Fig. 1
Short Form (SF)-12 scores (physical component score (PCS) and mental component score (MCS)) over time by solution.
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Patient demographics. A total of 1860 patients were
included, 1850 of whom completed the SF-12 and 1833 the
EQ-5D. The patient demographics and injury characteris-
tics are similar to the overall FLOW cohort (Table I).3
Mean age was 45.4 years (SD 17.6) and most (n = 1273,
68.4%) were men.
Results
Most patients had a leg injury (n = 1306, 70.2%) and
underwent definitive fixation with a plate (n = 962, 51.7%)
or intramedullary nail (n = 635, 34.1%).
HRQL by irrigation pressures and solutions. We did not find
any significant differences in SF-12 PCS, SF-12 MCS or
EQ-5D utility scores between soap and saline or between
the three irrigation pressure groups over the one-year fol-
low-up period (Figs 1 to 3). Our adjusted analyses did not
show any significant differences when compared with the
main analyses, so unadjusted analyses are presented. We
did not find subgroup effects on any outcome measure of
fracture type or location.
In our analysis of the SF-12 PCS, we found a significant
interaction (p = 0.032) between solution and pressure. As
both variables had been included in the same model, we
also included interaction terms between solution and time,
and between pressure and time. In this model, the interac-
tion was still significant (p = 0.032) but the interactions
between time point and solution, and between time point
and pressure were not significant (p = 0.88 and p = 0.54,
respectively).
In order to evaluate the magnitude and nature of the
interaction between pressure and solution, we examined
the effect of solution within each level of pressure, and the
effect of pressure within each level of solution (Table II).
Since this interaction was an unexpected finding, we sought
to objectively evaluate its credibility. We elected to adapt
criteria that have previously been used to assess the credi-
bility of a sub-group analysis17 to determine if our observed
interaction was believable. Based upon the application of
these criteria, we determined that this finding had low cred-
ibility (Table III).
HRQL at one-year post-injury. One year post-injury, most
patients had not regained their pre-injury HRQL by any of
the three outcome measures (p < 0.001). Patients’ mean SF-
12 PCS at one year was 10.01 (95% confidence interval
(CI) 9.38 to 10.64) points lower than their pre-injury score,
and their mean SF-12 MCS was 2.61 (95% CI 1.97 to 3.25)
points lower than prior to injury. Patients’ EQ-5D mean
utility scores were 0.15 (95% CI 0.14 to 0.16) lower than
Fig. 2
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pre-injury. At one year, patients had returned to 81% of
their PCS, 95% of their MCS and 84% of their ED-5D util-
ity score.
Discussion
We found no differences between irrigation pressures in the
SF-12 PCS, SF-12 MCS and EQ-5D utility score. This ech-
oes the findings of our primary study. Analysis of the SF-12
and the EQ-5D did not capture the difference between the
composition or pressure of the delivery system for the irri-
gation solutions which was seen in our primary study. This
may have been because the outcome measures were not suf-
ficiently responsive to capture the relatively small differ-
ences in HRQL resulting from only 41 more patients
undergoing re-operation in the soap group when compared
with the saline group.
In our analysis of the SF-12 PCS, the significant interac-
tion (p = 0.032) between solution and pressure was unex-
pected, given that the initial FLOW analysis had found no
such interaction. The size of the interaction was relatively
small, constituting less than half of the minimum important
difference of five points for the SF-12 PCS. No such inter-
action was seen with the SF-12 MCS, for the EQ-5D utility
score, or in the re-operation rate in the original study. There
is no basic scientific rationale to support the existence of
such an interaction. Consequently, based on the application
of the adapted criteria, we concluded that the observed
interaction was not highly plausible, and was most likely a
spurious finding.
We found that patients with open fractures had not
returned to their pre-injury status at one-year post-injury.
This is in keeping with the results of the Study to Prospec-
tively Evaluate Reamed Intramedullary Nails in Tibial
Fractures (SPRINT) trial, which also reported a reduction
of 10 points in the PCS of the SF-36 over the same time
period in open and closed tibial fractures.19 The EQ-5D
scores were 0.15 points lower at one year, which also rep-
resents a clinically important difference.11 The SF-12 MCS,
by contrast, was 2.66 points lower and hence not a clini-
cally important difference. These findings are also consist-
ent with the results of the SPRINT trial, which found the
SF-36 MCS to be approximately 2 points lower at one
year.19 Similarly, a recent study of functional recovery in
patients with tibial fracture reported that HRQL had not
Fig. 3
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returned to baseline at one year or at five years post-
injury.20 Several other studies in the literature reflect this.21-
23
A strength of our study is its large, multicentre, rand-
omized controlled nature, with a sample size that exceeds
the a priori calculation, and its use of standardized, vali-
dated outcome measures. This is one of the largest studies
to date of its kind and the inclusion of over 40 clinical sites
in five countries increases the ability to generalize from our
results.
Despite these strengths, our study has several limitations.
The method of recording pre-injury quality of life may be
prone to recall bias, although previous research has sug-
gested that the level of bias is minimal.24 We did not include
any anatomical- or disease-specific outcome measures; typ-
ically, these do not provide such granular data on the global
effect on HRQL and add a significant documentation bur-
den to a trial enrolling patients with potentially diverse pat-
terns of injury. This can, in turn, affect recruitment and
retention rates.
Table II. Effect of treatment group on Short Form-12 physical component scores (PCS) at 12 months
Mean difference between 12-month PCS (95% CI)*
At high pressure
Soap vs saline 1.18 (0.02 to 2.33)
At low pressure
Soap vs saline 0.45 (-0.71 to 1.61)
At very low pressure
Soap vs saline -0.99 (-2.16 to 0.18)
With soap
High vs low -0.12 (-1.28 to 1.04)
High vs very low 0.51 (-0.64 to 1.67)
Low vs very low 0.63 (-0.53 to 1.79)
With saline
High vs low -0.84 (-2.00 to 0.31)
High vs very low -1.65 (-2.82 to -0.48)
Low vs very low -0.81 (-1.98 to 0.36)
*from the main 3-level model
CI, confidence interval
Table III. Assessment of credibility of interaction between pressure and solution for Short Form (SF)-12 physical component scores (PCS)
Criteria* Assessment
Is the interaction variable a characteristic measured at baseline or after 
randomization?
Measured at the time of randomisation
Is the effect suggested by comparisons within rather than between studies?Yes, it is suggested by comparisons within a single study rather than 
between studies
Was the hypothesis specified a priori? Our a priori hypothesis was that there would be an interaction between 
pressure and solution
Was the direction of the interaction effect specified a priori? We were unable to find a compelling reason to specify a direction of a 
possible effect modification
Was the interaction effect one of a small number of hypothesized effects 
tested?
We looked at the following three interactions: randomized solution with 
randomized pressure, randomized solution with time of HRQL assess-
ment and randomized pressure with time of HRQL assessment
Does the interaction test suggest a low likelihood that chance explains 
the apparent subgroup effect?
We obtained p = 0.032 for the interaction term, which suggests a low 
likelihood that chance explains the apparent effect
Is the significant interaction effect independent? The interaction was not influenced by the inclusion of other interaction 
terms in the analysis
Is the size of the interaction effect large? No, the size of the effect is less than half of the minimum clinically 
important difference for the SF-12 PCS
Is the interaction consistent across studies? Not applicable, as no other studies have evaluated this interaction
Is the interaction consistent across closely related outcomes within this 
study?
No, this interaction was not observed for the SF-12 MCS or the EQ-5D 
index score. Also, no interaction was observed between pressure and 
solution for the primary study outcome of reoperation within 12 
months
Is there indirect evidence that supports the hypothesized interaction 
(biological rationale)
No, there is no biological rationale for the observed interaction
*Adapted from criteria developed to evaluate the credibility of subgroup analyses17,18
HRQL, health-related quality of life; EQ-5D, EuroQol-5 Dimensions
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This study may also be limited by its follow-up.
Although one year is a frequently used follow-up period in
fracture research, it may be insufficient to evaluate recovery
fully. We were able to include 76% of patients enrolled in
the FLOW study in this analysis; while this demonstrates a
not insignificant loss to follow-up, this is a comparable pro-
portion with that seen in previous orthopaedic trauma tri-
als.19
These results show that neither irrigation pressure nor
the composition of the solution have an effect on patients’
HRQL within 12 months of open fracture. Despite modern
fracture implants and high-quality care, patients are not
returning to pre-injury status within 12 months. This can
guide both surgeon and patient expectations after open
fracture. It also suggests that factors other than surgical
treatment may be important, and that non-surgical inter-
ventions may be necessary to help patients recover.
Future research needs to look beyond surgical technique
and consider the influence of psychological support, social
circumstances and co-morbidity on outcome. Although
generic measures detected decrements in HRQL at one year,
they may not be sufficient to capture the much smaller dif-
ferences in clinically important outcomes in open fracture
trials. Future methodological research is needed to under-
stand better the assessment of HRQL in patients with open
fractures.
Take home message:
- Irrigation solution and irrigation pressure do not have an
effect on 12-month post-open fracture HRQL.
- Despite the use of modern fracture implants and high-quality surgical
care, patients sustaining open fractures do not return to their pre-injury
HRQL at 12 months post-injury.
Supplementary material
A full list of the FLOW investigators and details of
the funding is available alongside the online version
of this article at www.bjj.boneandjoint.org.uk
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